Strukturelle Abwandlungen an Nukleotiden,Nukleosiden und Nukleosidbasen mit β-Acylvinylphosphoniumsalzen

β-Acetylvinyl-triphenylphosphonium bromide1 reacts with CMP to form the 3,N⁴-etheno-derivative {[6-(5′-phosphoribofuranosyl)-2-methyl-5-oxo-imidazo [1.2-c]pyrimidin-3-yl]-methyl}triphenyl-phosphonium bromide (2). Guanine affords mainly the lin. condensation product [(6-methyl-9-oxo-imidazo[1.2-a]-purin-7-yl)-methyl]triphenylphosphonium bromide (3) and the angular tricyclic product [(6-methyl-9-oxo-imidazo[2.1-b]purin-5-yl)-methyl]-triphenylphosphonium bromide (4). For comparison we synthesized the angular condensed heterocycle5, (6.8-dimethyl-9-oxo-imidazo[2.1-b]purin-5-yl)-methyl]triphenylphosphonium bromide, by reaction of 1-methylguanine with1, and the corresponding linear derivative6 [(4.6-dimethyl-9-oxo-imidazo[1.2-a]purin-7-yl)-methyl]-triphenylphosphoniumbromide from 3-methylguanine and1. AHofmann-type degradation of3 with the anion of diethyl malonate led to7, diethyl (6-methyl-9-oxo-imidazo[1.2-a]purin-7-yl)-methylmalonate, a compound whose structure resembles some Y-bases in t-RNA.Wittig reaction of the silylated nucleoside derivative8 a {[2-methyl-5-oxo-6-(2′.3′.5′-tris-trimethylsilyl)-ribofuranosyl-imidazo[1.2-c]pyrimidin-3-yl]methyl}-triphenylphosphonium bromide, with C₆H₅CHO resulted in the 2-methyl-3(ω-styryl)-6[2′.3′.5′-tris-(trimethylsilyl)]ribofuranosyl-imidazo[1.2-c] pyrimidin-5-one (9).     

Synthesis and Enzymic Hydrolysis of Acylated Adenosine Derivatives

Abstract

Various derivatives of adenosine were prepared by acylation of adenosine (6‐amino‐9‐(β‐D‐ribofuranosyl)purine (1) with different molar equivalents of acetic anhydride and/or pivaloyl chloride in pyridine. Compounds 6‐acetylamino‐9‐[(2,3,5‐tri‐O‐acetyl)‐β‐D‐ribofuranosyl]purine (3), 6‐amino‐9‐[(2,3,5‐tri‐O‐acetyl)‐β‐D‐ribofuranosyl]purine (4), and 6‐pivaloylamino‐9‐[(2,3,5‐tri‐O‐pivaloyl)‐β‐D‐ribofuranosyl]purine (5) were subsequently submitted to hydrolysis catalyzed by a number of hydrolytic enzymes. Regioselective enzymic deacetylation at the primary hydroxyl group of 3 and 4 with butyrylcholinesterase (BChE) produced 6‐acetylamino‐9‐[(2,3‐di‐O‐acetyl)‐β‐D‐ribofuranosyl]purine (9) and 6‐amino‐9‐[(2,3‐di‐O‐acetyl‐β‐D‐ribofuranosyl]purine (10), respectively. All structures were established by ¹H and ¹³C NMR spectroscopies.     

Synthesis of heterocycles. Part VI. Synthesis and antimicrobial activity of some 4-amino-5-aryl-1,2,4-triazole-3-thiones and their derivatives

4-Amino-5-aryi-1,2,4-triazole-3-thiones I react with acid chlorides to yield 4-acylamino-5-aryl-1,2,4-triazole-3-thiones II. Compounds I also react with methylene iodide, chloroacetonitrile and methyl bromoacetate to give bis-(4-amino-5-aryl-1,2,4-triazol-3-ylthio)methanes III, 4-amino-5-aryl-3-cyanomethylthio-1,2,4-triazoles IV and 4-amino-5-aryl-3-carbomethoxymethylthio-1,2,4-triazoles V, respectively. Compounds V react with hydrazine hydrate to give the corresponding acid hydrazides VI which in turn condenses with acid chlorides and aldehydes to afford respectively 1-[(4-amino-5-aryl-1,2,4-triazol-3-ylthio)acetyl]-2-aroylhydrazines VII and aryl methylene (4-amino-5-aryl-1,2,4-triazol-3-ylthio)acethydrazones VIII. The antimicrobial activities of the above compounds were screened against different strains of bacteria and fungi.     

A new method for the synthesis of 6H,11H-indolo[3,2-c]-isoquinolin-5-ones/thiones and their reactions

The synthesis of 8-substituted and unsubstituted 6H,11H-indolo[3,2-c]isoquinolin-5-ones/thiones 3a-c and 4a-c and their derivatives viz, ethyl (8-substituted-6H,11H-indolo[3,2-c]isoquinolin-5-on-6-yl)acetates 5a-c , (8-substituted-6H,11H-indolo[3,2-c]isoquinolin-5-on-6-yl)acetyl hydrazides 6a-c , 3,5-disubstituted-pyrazoles 7a-c and 8a-c , 3-substituted-pyrazol-5-ones 9a-c and 5-(8-substituted-6H,11H-indolo[3,2-c]isoquinolin-5-on-6-yl)methyl-1,3,4-oxadiazole-2-thiones 10a-c , also ethyl (8-substituted-11H-indolo[3,2-c]isoquinolin-5-ylthio)ace-tates 11a-c , (8-substituted-11Hindolo[3,2-c]isoquinolin-5-ylthio)acetyl hydrazides 12a-c , 3,5-disubstituted-pyrazoles 13a-c and 14a-c , 3-substituted-pyrazol-5-ones 15a-c and 5-(8-substituted-11H-indolo[3,2-c]isoquin-olin-5-yl)thiomethyl-1,3,4-oxadiazole-2-thiones 16a-c is described.     

Synthesis of an acyclic nucleoside analog of highly fluorescent luminarosine

Photoirradiation of 1-{9-[(2-acetoxyethoxy)methyl]-9H-purin-6-yl}-pyridinium chloride (1b) in aqueous solution leads to two photoproducts, namely 1-{5-formamido-6-[(2-acetoxyethoxy)methylamino]pyrimidin-4-yl}pyridinium chloride (2b) and 1-(6-(acetoxymethyl)-5,5a,6,8-tetrahydrooxazolo[4,3-e]purin-4-yl)pyridinium chloride (6), which constitutes a new heterocyclic system. Further, photosensitized irradiation of 2b gave the desired acyclic nucleoside analog of the highly fluorescent luminarosine 3b.     

Synthesis and Characterization of Some Novel Higher C,N-Diphenyl Nitrones,Isoxazolines, and Mercaptobenzimidazoles as Oleochemicals

Abstract

Some novel long-chain nitrones, isoxazolines, and (1H-benzo[d]-imidazol-2-ylthio) derivatives were synthesized. Nitrones, N-{4-[2-(tetradecylthio)acetoxy]benzylidene}aniline oxide, and N-[4-(12-oxo-2,5,8,11-tetraoxadocosan-22-yloxy)benzylidene]aniline oxide were prepared via the reaction of β-phenylhydroxylamine with the corresponding aromatic aldehydes. The isoxazolines were prepared from undec-10-en-1-ol and benzonitrile-N-oxide which was generated in situ. The 1H-benzo[d]-imidazol-2-ylthio derivatives were synthesized via the replacement reaction of ω-bromo esters and 2-mercaptobenzimidazole.     

Synthesis of substituted lysine-containing oligopeptides

Conclusions Oligopeptides containing lysine and alanine and having the following sequences were obtained: BOC-[(N-Cb)-Lys]₆OCH₃, BOC-[(N-Cb)-Lys]₈OCH₃, BOC-Ala-[(N-Cb)-Lys]₄-Ala-OCH₃, and BOC-Ala-[(N-Cb)-Lys]₆-Ala-OCH₃.Translated from Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, No. 8, pp. 1858–1860, August, 1972.     

Inclusion of quaternary ammonium compounds by calixarenes

In weakly polar solvents, strong association occurs between calixarene anions and tetraalkylammonium cations, with the magnitude of the observed equilibrium constants depending upon the charge on the anion, the solvent, the ring size of the calixarene and the nature of the alkyl group of the cation. Large upfield shifts of the methyl resonances of the [(CH₃)₄N]⁺ cation in solutions of [(CH₃)₄N]₂[p-t-butylcalix[6]arene-2H] indicate cation inclusion in a structure which is possibly identical with that found for the solid salt by X-ray crystallography. This shows one of the cations to be included within a partial cone structure of a hinged 3-up, 3-down conformation of the calixarene. The functionalised tetramethylammonium ions, choline and acetyl choline, are also strongly included by various calixarene anions but attempts to detect significant modification of the reactivity of acetyl choline resulting from inclusion have not been successful.This paper is dedicated to the commemorative issue on the 50th anniversary of calixarenes.     

Tumor‐Promoting Diterpene Esters from Latex of Euphorbia cauducifolia L.

Tumor‐promoting characteristics of seven esters, 1 – 7 , obtained from the latex of Euphorbia cauducifolia L. was appraised by carrying out NMRI mice back skin. The structures of 1 – 7 were elucidated by spectroscopic techniques like ¹H‐ and ¹³C‐NMR, 2D‐NMR (HMQC, HMBC, HOHAHA (homonuclear Hartmann–Hahn), NOESY, and NOE), FT‐IR, UV, and MS as esters of 17‐hydroxyingenol, namely 17‐[(2Z,4E,6Z)‐deca‐2,4,6‐trienoyloxy]ingenol ( 1 ), 3‐O‐angeloyl‐17‐[(2Z,4E,6Z)‐deca‐2,4,6‐trienoyloxy]ingenol ( 2 ), 3‐O‐acetyl‐20‐O‐angeloyl‐17‐hydroxyingenol ( 3 ), 17‐(acetyloxy)‐3‐O‐angelyl‐ingenol ( 4 ), 20‐O‐acetyl‐3‐O‐angeloyl‐17‐hydroxyingenol ( 5 ), 3‐O‐angelyl‐17‐(benzoyloxy)ingenol ( 6 ) and 20‐O‐acetyl‐3‐O‐angelyl‐17‐(benzoyloxy)ingenol ( 7 ). Compounds 1 – 4 were isolated for the first time, whereas 5 – 7 are known metabolites but detected for the first time in this plant. Biological investigations revealed that these compounds are tumor promoters.     

Synthesis of some substituted dibenzodiazepinones and pyridobenzodiazepinones

Some fluoro- and iodo-derivative of 5-[[4-[(4-diisobutylamino)butyl]-1-phenyl]acetyl]-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-1l-one and 11-[[4-[(dialkylamino)butyl]-1-phenyl]acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-ones 6 (Scheme 1) and their analogues were synthesized. The synthesis of dibenzodiazepinones 1 (Scheme 1) is based on the reaction between 1,4-phenylenediamine and substituted benzoic acids. The intermediate pyridobenzodiazepinones 3 (Scheme 1) were prepared by condensation of 2-chloro-3-aminopyridine with methyl anthranilate and its chlorine derivative. The condensation of 4-[(halo)alkyl]phenylacetyl chloride with dibenzodiazepinones and pyridobenzodiazepinones followed by the reaction of mono- or dialkyl- or dialkenylamine provides 6 (Scheme 1).     

Synthesis and characterization of mono- and bicyclic heterocyclic derivatives containing 1,2,4-triazole, 1,3,4-thia-, and -oxadiazole rings

A series of new N- and S-substituted 1,3,4-oxadiazole derivatives were synthesized. 5-Pyridin-3-yl-3-[2-(5-thioxo-4,5-dihydro-l,3,4-thiadiazol-2-yl)ethyl]-1,3,4-oxadiazole-2(3H)-thione and 5-[(5-(pyridin-3-yl)-1,3,4-oxadiazol-2-ylthio)methyl]-N-phenyl-1,3,4-thiadiazol-2-amine were formed by cyclization of 3-(5-pyridin-3-yl-2-thioxo-1,3,4-oxadiazol-3(2H)-ylpropanimidohydrazide and 2-[(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)thio]thiosemicarbazide with CS₂ and H₂SO₄. On the other hand, a number of new bicyclic 1,2,4-triazolo[3,4-b][1,3,4]thiadiazole derivatives were synthesized. 6-Pyridin-3-ylbis[1,2,4]‐triazolo[3,4-b:4′,3′-d][1,3,4]thiadiazole-3(2H)-thione was synthesized by reaction of 6-(hydrazino)-3-pyridine-3-yl[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole with CS₂/KOH/EtOH. The structures of the newly synthesized compounds were elucidated by the spectral and analytical data IR, Mass, and ¹H NMR spectra. Correspondence: Adel A.-H. Abdel-Rahman, Department of Chemistry, Faculty of Science, Menoufia University, Shebin El-Koam, Egypt; Wael A. El-Sayed, National Research Centre, Department of Photochemistry, Cairo, Egypt.     

The Synthesis of Some Novel N-[a-(Isoflavone-7-O-)Acetyl ] Amino Acid Derivatives

A series of novel N-[(α)-(isoflavone-7-O-)acetyl] amino acid methyl esters were prepared from the efficient and regioselective alkylation of isoflavones with chloroacetyl amino acid derivatives under mild condition.     

Synthesis and biological evaluation of peptidyl organotrifluoroborates and their corresponding boron analogs

Six peptidyl organotrifluoroborates and their corresponding boronate esters and/or boronic acid analogs were designed and synthesized. Their anti-proliferative activity against hepatocellular carcinoma cells (HepG2) and human metastatic breast cancer cells (MDA-MB231) were evaluated by use of an MTT assay. Potassium {4-[(3S,6S,9S)-3,6-dibenzyl-9-isopropyl-4,7,10-trioxo-11-oxa-2,5,8-triazadodecyl]phenyl}trifluoroborate (B6) was potent (IC₅₀ = 29.9 μM) against MDA-MB231, and {4-[(3S,6S,9S)-6-benzyl-3-((benzyloxy)methyl)-9-isopropyl-4,7,10-trioxo-11-oxa-2,5,8-triazadodecyl]phenyl}boronic acid (B9) and Potassium {4-[(3S,6S,9S)-6-benzyl-3-((benzyloxy)methyl)-9-isopropyl-4,7,10-trioxo-11-oxa-2,5,8-triazadodecyl]phenyl}trifluoroborate (B10) had broad anti-proliferative activity against HepG2 (IC₅₀ = 24.7 and 21.8 μM, respectively) and MDA-MB231 (IC₅₀ = 24.5 and 18.9 μM, respectively).     

Acylglycerols (=Glycerides) from the Glandular Trichome Exudate on the Leaves of Paulownia tomentosa

Chemical investigations of the glandular trichome exudates on the leaves of Paulownia tomentosa (Scrophulariaceae) led to the identification of the thirty acylglycerols (=glycerides) 1 – 30 , including five known ones ( 2, 3, 6, 9 , and 15 ) (Fig. 1). Spectroscopic analysis combined with GC/MS studies of the glycerides and the liberated fatty acids, in the form of trimethylsilyl ether derivatives and trimethylsilylated methyl esters, respectively, established that the constituents belonged to 1,3‐di‐O‐acetyl‐2‐O‐(fatty acyl)glycerols, 1‐O‐acetyl‐2‐O‐(fatty acyl)‐sn‐glycerols, and 2‐O‐(fatty acyl)glycerols, wherein the fatty acyl moiety was either an eicosanoyl or an octadecanoyl group bearing OH and/or AcO groups at the 3‐, 3,6‐, 3,7‐, 3,8‐, or 3,9‐positions. The 1‐O‐acetyl‐2‐O‐[(3R,6S)‐3‐(acetyloxy)‐6‐hydroxyeicosanoyl]‐sn‐glycerol ( 12 ; 20% of the total glycerides), 2‐O‐[(3R,8R)‐3,8‐bis(acetyloxy)eicosanoyl]glycerol ( 17 ; 14%), 2‐O‐[(3R,9R)‐3,9‐bis(acetyloxy)eicosanoyl]glycerol ( 18 ; 12%), and 2‐O‐[(3R)‐3‐(acetyloxy)eicosanoyl]glycerol ( 10 ; 12%) were relatively abundant constituents. The configurations of the stereogenic centers of the fatty acyl moieties were determined by ¹H‐NMR analysis of the monoesters obtained from (R)‐ and (S)‐2‐(naphthalen‐2‐yl)‐2‐methoxyacetic acid ((R)‐ and (S)‐2NMA? OH and the hydroxy‐substituted fatty acid methyl esters (Fig. 2). The configuration at C(2) of the glycerol moiety of the 1‐O‐acetyl‐2‐O‐(fatty acyl)glycerols was determined to be (2S) by chemical conversion of, e.g., G‐2 (= 2 / 3 1 : 10) to (+)‐3‐O‐[tert‐butyl)diphenylsilyl]‐sn glycerol of known absolute configuration.     

Synthesis of 6-amino-4-aryl-5-cyano-3-(3-cyanopyridin-2-ylthiomethyl)-2,4-dihydropyrano[2,3-c]pyrazoles and their hydrogenated analogs. Molecular structure of 6-amino-5-cyano-3-(3-cyano-4,6-dimethylpyridin-2-ylthiomethyl)-4-(2-nitrophenyl)-2,4-dihydropyrano[2,3-c]pyrazole

Substituted 3-hydroxypyrazoles, which were prepared based on ethyl esters of substituted 4-(pyridin-2-ylthio)- or 4-(1,4-dihydropyridin-2-ylthio)acetoacetic acids and hydrazine hydrate, were used in the synthesis of 6-amino-4-aryl-5-cyano-3-(pyridin-2-ylthiomethyl)-2,4-dihydropyrano[2,3-c]pyrazoles. The molecular and crystal structure of 6-amino-5-cyano-3-(3-cyano-4,6-dimethylpyridin-2-ylthiomethyl)-4-(2-nitrophenyl)-2,4-dihydropyrano[2,3-c]pyrazole was established by X-ray diffraction analysis.     

On the use of carboxamidomethyl esters in the protease-catalyzed peptide synthesis

Carboxamidomethyl esters (CAM esters) ofZ- andBoc-protected alanine and phenylalanine were prepared in order to investigate their usefulness as substrates for -chymotrypsin- and papain-catalyzed hydrolysis and peptide synthesis reactions. The easy removal of theCAM-C-protecting group under mild conditions and dependent on the enzyme specificity was demonstrated. Examples are given for the protease-catalyzed synthesis of various peptide derivatives usingCAM esters as C- and N-components in aqueous-organic media. Comparatively short reaction times were observed. Abbreviations: IUPAC-IUB rules for peptides are followed, see Eur. J. Biochem. (1972) 27: 201.Ac = acetyl,Bz = benzoyl,Boc =tert-butyloxycarbonyl,Z = benzyloxycarbonyl, -OBu ^t =tert-butyl ester, -CAM = carboxamidomethyl ester,-OEt = ethyl ester, -OMe = methyl ester, TLC = thin layer chromatography.     

Synthesis and reduction of esters of N-(4-amino-5-nitro-6-pyrimidyl)amino acids

The reaction of esters of amino acids with 4-amino-6-chloro-5-nitropyrimidine has yielded esters of (4-amino-5-nitro-6-pyrimidyl)amino acids. The reduction of the esters of -(4-amino-5-nitro-6-pyrimidylamino) acids has yielded 4-amino-6-hydroxy-7,8-dihydropteridines. -(4-Amino-5-nitro-6-pyrimidylamino) acids and the ester of N-(4-amino-5-nitro-6-pyrimidyl)--alanine do not cyclize and on reduction give the corresponding diaminopyrimidine derivatives.     

Prostanoids: LXXXII. Synthesis of Key Precursors of 9-LO Thromboxans

Starting from levoglucosan, methyl 2,4-dideoxy-3-O-mesyl-4-C-[(2Z)-octenyl]--D-arabino-hexopyranoside and (+)-2-methoxy-6-[6-methoxycarbonyl-3-oxo-(1E)-hexenyl]-5-[(2Z)-octenyl]pyran-3-one were synthesized as potential building blocks for preparation of 9-LO thromboxanes.     

Seven membered ring chelates derived from γ-hydroxyamides and triphenyltin or diphenylboron

N-Benzyl-4-hydroxy-butyramide (1), 4-hydroxy-N-[(R)-1-phenyl-ethyl]-butyramide (2), and (R)-4-hydroxy-2-methyl-N-[(R)-1-phenyl-ethyl]-butyramide (3a) were used to prepare new diphenylboron and triphenyltinoxy compounds: diphenylborinic acid 3-benzylcarbamoyl-propyl ester (4), diphenylborinic acid 3-[(R)-1-phenyl-ethylcarbamoyl]-propyl ester (5) and diphenylborinic acid (R)-3-[(R)-1-phenyl-ethylcarbamoyl]-butyl ester (6), N-benzyl-4-triphenyltinoxy-butyramide (7), 4-triphenyltinoxy-N-[(R)-1-phenyl-ethyl]-butyramide (8), and (R)-4-triphenyltinoxy-2-methyl-N-[(R)-1-phenyl-ethyl]-butyramide (9). The X-ray diffraction analysis of a crystalline structure of the new γ-hydroxyamide 3a is reported, as well as that of the first example of a crystalline structure where a diphenylborinic ester forms a seven membered chelate, by a carbonyl coordination to boron (4). Structural studies of tin and boron esters were performed by NMR. The CO internal coordination to tin atoms, affording seven membered rings, was observed by ¹¹⁹Sn NMR experiments at low temperature.     

Synthesis,spectroscopic, magnetic and biological activity studies of copper(II) complexes of an antipyrine Schiff base

The Schiff base, 4-(2-pyrrolylmethylideneamino)antipyrine (HPAP), (1), and its copper(II) complexes were synthesized and characterized by elemental analysis and by physical and spectral methods such as i.r., u.v.–vis., ¹H-n.m.r., ¹³C-n.m.r. and e.s.r. as well as by molar conductance and magnetic moment determinations. Both the bis-ligand, [(HPAP)₂Cu]X₂ (4, 5), [(PAP)₂Cu] (6), and the dimer, [(PAP)Cu]₂X₂ (2, 3), complexes were isolated. In these complexes, the Schiff base acts as a bidentate or tridentate neutral or monobasic ligand. Interaction of the isolated [(PAP)Cu]₂Cl₂ (2), with strong coordinating organic bases was studied and the resultant adducts, [(PAP)CuLs]Cl; Ls = pyridine (7), -picoline (8), -picoline (9), -picoline (10) or n-propylamine (11), were isolated and characterized. Biological activity screening was studied and an activity correlation coefficients matrix was constructed for HPAP and the copper(II) complexes against gram-positive, gram-negative and fungi species. The copper content, structure of the complex as well as the degree of exposure of the metal center control the biological activity of the isolated complexes.